title: Chitins and chitosans as immunoadjuvants and non-allergenic drug carriers.
abstract: Due to the fact that some individuals are allergic to crustaceans, the presumed relationship between allergy and the presence of chitin in crustaceans has been investigated. In vivo, chitin is part of complex structures with other organic and inorganic compounds: in arthropods chitin is covalently linked to proteins and tanned by quinones, in fungi it is covalently linked to glucans, while in bacteria chitin is diversely combined according to Gram(+/-) classification. On the other hand, isolated, purified chitin is a plain polysaccharide that, at the nano level, presents itself as a highly associated structure, recently refined in terms of regularity, nature of bonds, crystallinity degree and unusual colloidal behavior. Chitins and modified chitins exert a number of beneficial actions, i.e., (i) they stimulate macrophages by interacting with receptors on the macrophage surface that mediate the internalization of chitin particles to be degraded by lysozyme and N-acetyl-beta-glucosaminidase (such as Nod-like, Toll-like, lectin, Dectin-1, leukotriene 134 and mannose receptors); (ii) the macrophages produce cytokines and other compounds that confer non-specific host resistance against bacterial and viral infections, and anti-tumor activity; (iii) chitin is a strong Th1 adjuvant that up-regulates Th1 immunity induced by heat-killed Mycobacterium bovis, while down- regulating Th2 immunity induced by mycobacterial protein; (iv) direct intranasal application of chitin microparticles into the lung was also able to significantly down-regulate allergic response to Dermatophagoids pteronyssinus and Aspergillus fumigatus in a murine model of allergy; (v) chitin microparticles had a beneficial effect in preventing and treating histopathologic changes in the airways of asthmatic mice; (vi) authors support the fact that chitin depresses the development of adaptive type 2 allergic responses. Since the expression of chitinases, chitrotriosidase and chitinase-like proteins is greatly amplified during many infections and diseases, the common feature of chitinase-like proteins and chitinase activity in all organisms appears to be the biochemical defense of the host. Unfortunately, conceptual and methodological errors are present in certain recent articles dealing with chitin and allergy, i.e., (1) omitted consideration of mammalian chitinase and/or chitotriosidase secretion, accompanied by inactive chitinase-like proteins, as an ancestral defensive means against invasion, capable to prevent the insurgence of allergy; (2) omitted consideration of the fact that the mammalian organism recognizes more promptly the secreted water soluble chitinase produced by a pathogen, rather than the insoluble and well protected chitin within the pathogen itself; (3) superficial and incomplete reports and investigations on chitin as an allergen, without mentioning the potent allergen from crustacean flesh, tropomyosine; (4) limited perception of the importance of the chemical/biochemical characteristics of the isolated chitin or chitosan for the replication of experiments and optimization of results; and (5) lack of interdisciplinarity. There is quite a large body of knowledge today on the use of chitosans as biomaterials, and more specifically as drug carriers for a variety of applications: the delivery routes being the same as those adopted for the immunological studies. Said articles, that devote attention to the safety and biocompatibility aspects, never reported intolerance or allergy in individuals and animals, even when the quantities of chitosan used in single experiments were quite large. Therefore, it is concluded that crab, shrimp, prawn and lobster chitins, as well as chitosans of all grades, once purified, should not be considered as "crustacean derivatives", because the isolation procedures have removed proteins, fats and other contaminants to such an extent as to allow them to be classified as chemicals regardless of their origin.
authors.affiliation: University of Ancona, Ancona, Italy. Muzzarelli.raa@gmail.it
authors.forename: Riccardo A A
authors.initials: RA
authors.lastname: Muzzarelli
mesh_terms: D054392:Adipokines; D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D001249:Asthma / Q000209:etiology / Q000276:immunology; D002686:Chitin / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology*; D000071451:Chitinase-3-Like Protein 1; D002688:Chitinases / Q000378:metabolism; D048271:Chitosan / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology*; D004337:Drug Carriers; D006023:Glycoproteins / Q000502:physiology; D006801:Humans; D006967:Hypersensitivity / Q000209:etiology / Q000276:immunology; D037102:Lectins / Q000502:physiology
chemical_list: D054392:Adipokines; D000276:Adjuvants, Immunologic; C084533:CHI3L1 protein, human; D000071451:Chitinase-3-Like Protein 1; D004337:Drug Carriers; D006023:Glycoproteins; D037102:Lectins; D002686:Chitin; D048271:Chitosan; D002688:Chitinases
references.citation: Clin Chim Acta. 1991 Jun 14;199(2):185-94
references.pmid: 1908363
references.citation: Respir Med. 2007 Oct;101(10):2176-81
references.pmid: 17631992
references.citation: J Immunol. 1996 Nov 1;157(9):4173-80
references.pmid: 8892655
references.citation: Keio J Med. 2007 Mar;56(1):21-7
references.pmid: 17392594
references.citation: Chest. 2007 Sep;132(3):1007-14
references.pmid: 17873195
references.citation: Cell Mol Immunol. 2009 Feb;6(1):45-50
references.pmid: 19254479
references.citation: Infect Immun. 1997 May;65(5):1734-41
references.pmid: 9125555
references.citation: Clin Exp Allergy. 2006 Jul;36(7):960-8
references.pmid: 16839412
references.citation: Yonsei Med J. 2009 Feb 28;50(1):22-30
references.pmid: 19259344
references.citation: Science. 2004 Jun 11;304(5677):1577
references.pmid: 15192186
references.citation: J Allergy Clin Immunol. 2004 Aug;114(2):459-60
references.pmid: 15341031
references.citation: EXS. 1999;87:279-92
references.pmid: 10906967
references.citation: J Clin Lab Anal. 2005;19(3):128-32
references.pmid: 15900564
references.citation: Protein Sci. 2009 Mar;18(3):569-78
references.pmid: 19241384
references.citation: J Exp Med. 2008 Jan 21;205(1):13-7
references.pmid: 18195077
references.citation: Eur J Pharm Sci. 2008 Feb 5;33(2):166-76
references.pmid: 18248966
references.citation: J Exp Med. 1995 Nov 1;182(5):1527-36
references.pmid: 7595222
references.citation: J Immunol. 2003 Oct 1;171(7):3655-67
references.pmid: 14500663
references.citation: J Allergy Clin Immunol. 2005 Sep;116(3):497-500
references.pmid: 16159614
references.citation: J Allergy Clin Immunol. 2008 Jul;122(1):202-8, 208.e1-7
references.pmid: 18602573
references.citation: EXS. 1999;87:211-21
references.pmid: 10906962
references.citation: Clin Chem Lab Med. 2005;43(5):499-502
references.pmid: 15899671
references.citation: J Proteome Res. 2009 Apr;8(4):1631-8
references.pmid: 19714806
references.citation: EMBO J. 2005 Mar 23;24(6):1277-86
references.pmid: 15729357
references.citation: Curr Opin Immunol. 2008 Dec;20(6):684-9
references.pmid: 18938241
references.citation: J Pharm Pharmacol. 2009 Jan;61(1):3-12
references.pmid: 19126291
references.citation: Crit Rev Clin Lab Sci. 2008;45(6):531-62
references.pmid: 19003601
references.citation: Biochem J. 2009 Apr 28;420(1):1-16
references.pmid: 19382893
references.citation: Clin Lab. 2007;53(5-6):321-33
references.pmid: 17605408
references.citation: N Engl J Med. 2007 Nov 15;357(20):2016-27
references.pmid: 18003958
references.citation: J Biol Chem. 2000 Oct 20;275(42):32721-7
references.pmid: 10827089
references.citation: J Clin Invest. 2006 Jun;116(6):1642-50
references.pmid: 16710478
references.citation: Am J Respir Crit Care Med. 2009 Mar 15;179(6):449-56
references.pmid: 19106306
references.citation: J Allergy Clin Immunol. 2003 Mar;111(3):450-63; quiz 464
references.pmid: 12642820
references.citation: Microbiol Immunol. 1984;28(8):903-12
references.pmid: 6094990
references.citation: Expert Opin Drug Deliv. 2009 Mar;6(3):239-53
references.pmid: 19290841
references.citation: Infect Immun. 2005 Jan;73(1):385-94
references.pmid: 15618176
references.citation: Nat Rev Immunol. 2003 Jan;3(1):23-35
references.pmid: 12511873
references.citation: Biomaterials. 2008 May;29(14):2173-82
references.pmid: 18279951
references.citation: J Biol Chem. 2001 May 18;276(20):17497-506
references.pmid: 11297523
references.citation: Int J Pharm. 2009 Jul 30;377(1-2):120-7
references.pmid: 19454304
references.citation: Nature. 2007 May 3;447(7140):92-6
references.pmid: 17450126
references.citation: Science. 2004 Jun 11;304(5677):1678-82
references.pmid: 15192232
references.citation: Clin Exp Allergy. 2002 Dec;32(12):1794-800
references.pmid: 12653174
references.citation: Clin Exp Dermatol. 2009 Jan;34(1):55-60
references.pmid: 19076793
references.citation: N Engl J Med. 2007 Nov 15;357(20):2082-4
references.pmid: 18003965
references.citation: Annu Rev Immunol. 2007;25:193-219
references.pmid: 17129180
references.citation: Trends Parasitol. 2004 Mar;20(3):126-33
references.pmid: 15036034
references.citation: Cell. 2006 Feb 24;124(4):783-801
references.pmid: 16497588
references.citation: J Immunol. 2007 Oct 15;179(8):5367-77
references.pmid: 17911623
references.citation: Int Arch Allergy Immunol. 2009;149(4):369-77
references.pmid: 19295241
references.citation: Curr Opin Allergy Clin Immunol. 2009 Feb;9(1):60-6
references.pmid: 19532094
references.citation: J Allergy Clin Immunol. 2008 Nov;122(5):944-950.e3
references.pmid: 18845328
references.citation: J Immunol. 2009 Mar 15;182(6):3573-82
references.pmid: 19265136
references.citation: N Engl J Med. 2008 Mar 6;358(10):1073-5; author reply 1075
references.pmid: 18322291
references.citation: Acta Biomater. 2007 Nov;3(6):882-95
references.pmid: 17572163
references.citation: Acta Biomater. 2007 May;3(3):301-9
references.pmid: 17208527
references.citation: J Pharm Sci. 2009 May;98(5):1643-56
references.pmid: 18781621
references.citation: Immunobiology. 2009;214(2):87-99
references.pmid: 19167987
references.citation: Trends Immunol. 2007 Oct;28(10):419-22
references.pmid: 17826333
references.citation: J Immunol. 2000 Feb 1;164(3):1314-21
references.pmid: 10640745
references.citation: Gastroenterology. 2006 Feb;130(2):398-411
references.pmid: 16472595
references.citation: Clin Chim Acta. 2003 May;331(1-2):79-85
references.pmid: 12691867
references.citation: Viral Immunol. 2003;16(4):541-7
references.pmid: 14733740
references.citation: Lab Invest. 2008 Aug;88(8):883-95
references.pmid: 18490894
references.citation: Clin Exp Allergy. 2006 Nov;36(11):1457-61
references.pmid: 17083356
references.citation: Mar Biotechnol (NY). 2003 Jul-Aug;5(4):339-48
references.pmid: 14719162
references.citation: Vaccine. 1984 Mar;2(1):93-9
references.pmid: 6397928
references.citation: J Immunol. 1997 Sep 1;159(5):2462-7
references.pmid: 9278339
references.citation: Am J Respir Cell Mol Biol. 2008 Nov;39(5):530-5
references.pmid: 18474671
references.citation: Clin Exp Allergy. 2009 Jul;39(7):943-55
references.pmid: 19400900
references.citation: Infect Immun. 2001 Oct;69(10):6123-30
references.pmid: 11553551
references.citation: Curr Opin Biotechnol. 1998 Jun;9(3):270-7
references.pmid: 9650272
references.citation: BMC Immunol. 2002 Jul 04;3:7
references.pmid: 12098359
references.citation: J Immunol. 2005 May 15;174(10):6346-56
references.pmid: 15879135
references.citation: Carbohydr Res. 1986 Feb 1;146(2):251-8
references.pmid: 3955576
references.citation: J Infect Chemother. 2008 Apr;14(2):86-92
references.pmid: 18622669